MEDA

ORG:MEDANTA

Medanta - The Medicity

  • Stock

Last Close

1,072.90

22/11 09:59

Market Cap

334.78B

Beta: -

Volume Today

248.66K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
391.39M
-
465.74M
19.00%
568.79M
22.13%
average payables
1.31B
-
1.33B
1.37%
1.65B
23.75%
average receivables
1.21B
-
2.18B
80.12%
book value per share
52.03
-
53.93
3.64%
54.98
1.96%
64.09
16.55%
93.68
46.18%
capex per share
-12.04
-
-7.52
37.50%
-5.80
22.94%
-10.88
87.77%
-9.10
16.36%
capex to depreciation
-2.95
-
-1.64
44.52%
-1.18
27.72%
-2.12
78.90%
-1.57
25.61%
capex to operating cash flow
-1.94
-
-1.08
44.61%
-0.60
43.95%
-0.88
46.29%
-0.37
58.48%
capex to revenue
-0.21
-
-0.13
38.93%
-0.10
19.78%
-0.13
24.97%
-0.09
31.20%
cash per share
10.70
-
9.99
6.61%
11.51
15.13%
20.30
76.38%
50.57
149.15%
days of inventory on hand
8.71
-
43.28
397.01%
41.63
3.81%
35.89
13.79%
35.24
1.81%
days payables outstanding
44.25
-
146.91
232.01%
137.76
6.23%
90.31
34.44%
113.65
25.85%
days sales outstanding
48.39
-
41.03
-
26.31
35.88%
debt to assets
0.22
-
0.35
58.22%
0.35
0.77%
0.35
1.98%
0.27
22.68%
debt to equity
0.42
-
0.69
63.66%
0.67
2.11%
0.69
1.85%
0.46
32.67%
dividend yield
earnings yield
0.00
-
0.00
29.55%
0.00
21.07%
0.02
579.10%
0.02
27.07%
enterprise value
110.38B
-
111.46B
0.97%
112.74B
1.15%
114.33B
1.41%
140.13B
22.57%
enterprise value over ebitda
63.43
-
46.23
27.11%
48.17
4.19%
23.21
51.82%
20.47
11.81%
ev to operating cash flow
71.51
-
63.67
10.96%
46.63
26.76%
36.73
21.23%
21.74
40.80%
ev to sales
7.66
-
7.52
1.84%
7.88
4.82%
5.30
32.71%
5.20
1.92%
free cash flow per share
-5.84
-
-0.53
90.96%
3.82
824.18%
1.46
61.81%
15.76
980.36%
free cash flow yield
-0.01
-
-0.00
90.96%
0.01
824.18%
0.00
61.81%
0.03
749.10%
graham net net
-28.97
-
-41.85
44.46%
-39.88
4.72%
-32.09
19.53%
-7.76
75.82%
graham number
49.11
-
41.97
14.55%
37.65
10.29%
105.92
181.34%
162.84
53.73%
income quality
3.01
-
2.74
8.93%
7.45
171.78%
1.11
85.10%
1.43
29.30%
intangibles to total assets
0.00
-
0.00
474.57%
0.00
15.47%
0.00
25.90%
0.00
36.99%
interest coverage
1.01
-
2.47
144.39%
1.65
33.19%
4.60
178.31%
6.86
49.32%
interest debt per share
24.76
-
39.16
58.15%
39.72
1.43%
47.11
18.61%
46.29
1.73%
inventory turnover
41.91
-
8.43
79.88%
8.77
3.96%
10.17
16.00%
10.36
1.85%
invested capital
0.42
-
0.69
63.66%
0.67
2.11%
0.69
1.85%
0.46
32.67%
market cap
103.12B
-
103.64B
0.51%
104.12B
0.46%
104.43B
0.30%
136.59B
30.79%
net current asset value
-6.55B
-
-8.38B
27.97%
-8.10B
3.40%
-7.18B
11.34%
-1.08B
84.92%
net debt to ebitda
4.17
-
3.24
22.36%
3.68
13.63%
2.01
45.46%
0.52
74.21%
net income per share
2.06
-
1.45
29.55%
1.15
21.07%
7.78
579.10%
12.58
61.68%
operating cash flow per share
6.20
-
7.00
12.83%
9.62
37.47%
12.34
28.36%
24.87
101.44%
payables turnover
8.25
-
2.48
69.88%
2.65
6.64%
4.04
52.54%
3.21
20.54%
receivables turnover
7.54
-
8.90
-
13.87
55.97%
research and ddevelopement to revenue
0.00
-
0.00
61.11%
0.00
133.15%
0.00
45.00%
return on tangible assets
0.02
-
0.01
34.11%
0.01
21.56%
0.06
482.98%
0.08
26.92%
revenue per share
57.88
-
59.24
2.34%
56.90
3.94%
85.50
50.25%
103.94
21.57%
roe
0.04
-
0.03
32.03%
0.02
22.59%
0.12
482.65%
0.13
10.61%
roic
0.02
-
0.03
29.33%
0.04
36.37%
0.08
124.03%
0.10
19.63%
sales general and administrative to revenue
0.02
-
0.02
15.79%
0.02
14.24%
0.12
471.77%
shareholders equity per share
52.03
-
53.93
3.64%
54.98
1.96%
64.09
16.55%
93.68
46.18%
stock based compensation to revenue
0.01
-
0.00
58.97%
0.00
69.56%
tangible asset value
13.30B
-
13.41B
0.87%
13.75B
2.54%
16.10B
17.06%
24.23B
50.52%
tangible book value per share
53.40
-
53.59
0.36%
54.70
2.07%
63.84
16.71%
93.68
46.75%
working capital
1.93B
-
1.21B
37.26%
974.70M
19.40%
3.92B
302.43%
10.07B
156.71%

All numbers in (except ratios and percentages)